Literature DB >> 3126264

Participation of lipoxygenase products from arachidonic acid in the pathogenesis of cerebral vasospasm.

T Watanabe1, T Asano, T Shimizu, Y Seyama, K Takakura.   

Abstract

To examine the possible involvement of lipoxygenase products from arachidonic acid in the pathogenesis of delayed vasospasm after subarachnoid hemorrhage (SAH), we measured the contents of hydroxyeicosatetraenoic acids (HETEs) in the subarachnoid clot, the cerebrospinal fluid, and the basilar artery, using the canine "two-hemorrhage" model. Lipoxygenase activity in the subarachnoid clot and the basilar artery was measured, ex vivo, using samples obtained 7 days after SAH. For a quantitative analysis of HETEs, each sample was homogenized with either ice-cold saline or methanol. The lipid extract was then submitted to reverse-phase HPLC. The identity of each HETE was further confirmed using straight-phase HPLC and gas chromatography-mass spectrometry. When the basilar artery was homogenized with ice-cold saline, a significant increase in the 5-HETE content was observed on SAH day 8. However, when the artery was homogenized with methanol, HETEs were not detected. In the case of incubation in the presence of arachidonic acid and calcium ionophore A23187, the 5-lipoxygenase activity was remarkably increased in the basilar artery exposed to SAH, compared to that of normal dogs. The subarachnoid clot contained a significant amount of 12-HETE (average 1.8 nmol/g wet weight) from day 2 to day 8. The administration of 1,2-bis(nicotinamido)propane significantly ameliorated vasospasm in the two-hemorrhage model, simultaneously inhibiting the 5-lipoxygenase activity of the basilar artery. Our observations show that the activities of 12- and 5-lipoxygenases are significantly increased after SAH in the subarachnoid clot and the basilar artery, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3126264     DOI: 10.1111/j.1471-4159.1988.tb10585.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  Possible mechanism to induce protein kinase C-dependent arterial smooth muscle contraction after subarachnoid haemorrhage.

Authors:  S Ohta; J Nishihara; Y Oka; H Todo; Y Kumon; S Sakaki
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

Review 2.  Antioxidant therapy against cerebral vasospasm following aneurysmal subarachnoid hemorrhage.

Authors:  T Asano; T Matsui
Journal:  Cell Mol Neurobiol       Date:  1999-02       Impact factor: 5.046

3.  Immunohistochemistry of leukotriene C4 in experimental cerebral vasospasm.

Authors:  N Minami; E Tani; M Yokota; Y Maeda; I Yamaura
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

4.  PKC and Rho in vascular smooth muscle: activation by BOXes and SAH CSF.

Authors:  Gail J Pyne-Geithman; Sunil G Nair; Danielle N Caudell; Joseph F Clark
Journal:  Front Biosci       Date:  2008-01-01

5.  Oxidative stress in subarachnoid haemorrhage: significance in acute brain injury and vasospasm.

Authors:  R E Ayer; J H Zhang
Journal:  Acta Neurochir Suppl       Date:  2008

6.  Dexanabinol prevents development of vasospasm in the rat femoral artery model.

Authors:  Ramazan Durmaz; Ahmet Ozsandik; Varol Sahintürk; Kismet Civi; Cengiz Bayçu; Hilmi Ozden; Amselem Shimon
Journal:  Neurosurg Rev       Date:  2008-02-07       Impact factor: 3.042

Review 7.  Inflammatory Pathways Following Subarachnoid Hemorrhage.

Authors:  Kevin Min Wei Khey; Alec Huard; Sherif Hanafy Mahmoud
Journal:  Cell Mol Neurobiol       Date:  2019-12-05       Impact factor: 5.046

8.  Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: Experimental-Clinical Disconnect and the Unmet Need.

Authors:  Fumiaki Oka; David Y Chung; Michiyasu Suzuki; Cenk Ayata
Journal:  Neurocrit Care       Date:  2020-02       Impact factor: 3.210

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.